These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6743489)

  • 1. Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.
    Perucca E; Grimaldi R; Gatti G; Caravaggi M; Crema F; Lecchini S; Frigo GM
    Br J Clin Pharmacol; 1984 Jul; 18(1):37-43. PubMed ID: 6743489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of sustained release propranolol formulations.
    McAinsh J; Baber NS; Holmes BF; Young J; Ellis SH
    Biopharm Drug Dispos; 1981; 2(1):39-48. PubMed ID: 7236870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
    Ohashi K; Ebihara A; Kondo K; Usami M
    Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J; Degen PH; Racine-Poon A
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
    Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
    J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of long-acting propranolol ('Inderal' LA) in the management of elderly hypertensive patients.
    Hamdy C; Tovey D; Baber NS; McAinsh J
    Eur J Clin Pharmacol; 1982; 22(5):379-81. PubMed ID: 7117349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.
    Nicholls DP; Harron DW; McAinsh J; Castle WM; Barker NP; Shanks RG
    Br J Clin Pharmacol; 1982 Nov; 14(5):727-32. PubMed ID: 7138752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting propranolol (Inderal LA): pharmacokinetics, pharmacodynamics and therapeutic use.
    Mishriki AA; Weidler DJ
    Pharmacotherapy; 1983; 3(6):334-41. PubMed ID: 6361703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of a new sustained release preparation of propranolol in normal healthy volunteers.
    Biswas NR; Garg SK; Lal R; Kumar N; Gyawali K; Narendranath KA; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):436-8. PubMed ID: 3198297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
    Kubik MM; Gill B; Dawes PM
    Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.
    Flouvat B; Berlin I; Cournot A; Robinet D; Duchier J; Sarmini H; Rossi A
    Br J Clin Pharmacol; 1989 May; 27(5):539-45. PubMed ID: 2757878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on some properties of a long-acting preparation of propranolol.
    Shanks RG; Neill JD; Leahey WJ; Varma MP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():409s-411s. PubMed ID: 540460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and in-vitro/in-vivo correlation for propranolol hydrochloride extended-release bead products prepared using aqueous polymeric dispersions.
    Rekhi GS; Jambhekar SS
    J Pharm Pharmacol; 1996 Dec; 48(12):1276-84. PubMed ID: 9004191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical Michaelis-Menten elimination model for propranolol.
    McAinsh J; Gay MA
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):241-5. PubMed ID: 4085525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of slow-release propranolol (Inderal LA) 80, 160 and 320 mg orally daily in the treatment of angina pectoris.
    Odemuyiwa O; Peart I; Alberts C; Hall RJ
    Br J Clin Pract; 1990 Jan; 44(1):9-12. PubMed ID: 2317442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetic and pharmacodynamic study of four different brands of propranolol in normal volunteers.
    Biswas NR; Garg SK; Kumar N; Mukherjee S; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):515-9. PubMed ID: 2583878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
    Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
    Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of once daily long acting propranolol hydrochloride (Inderal LA and Half-Inderal LA) in the treatment of anxiety. A double-blind placebo-controlled general practice study.
    Hudson CF
    Br J Clin Pract; 1988 Oct; 42(10):419-26. PubMed ID: 3076469
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Eur J Clin Pharmacol; 1980 Jun; 17(6):419-24. PubMed ID: 7398733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Br J Clin Pharmacol; 1980 Jan; 9(1):33-40. PubMed ID: 7356891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.